Energy Stress Regulates Hippo-YAP Signaling Involving AMPK-Mediated Regulation of Angiomotin-like 1 Protein

DeRan, Michael, Yang, Jiayi, Shen, Che-Hung, Peters, Eric C., Fitamant, Julien, Chan, Puiyee, Hsieh, Mindy, Zhu, Shunying +5 more·2014·Cell Reports

Cited by (316)

Items 101–200 of 316

  1. New strategies for targeting glucose metabolism–mediated acidosis for colorectal cancer therapy
    Gang Wang, Junjie Wang, Peihao Yin, Ke Xu, Yu‐Zhu Wang, Feng Shi, Jing Gao, Xingli Fu · 2018 · Journal of Cellular Physiology
  2. Metabolic and Mechanical Cues Regulating Pluripotent Stem Cell Fate
    Tânia Perestrelo, Marcelo Correia, João Ramalho‐Santos, Denis Wirtz · 2018 · Trends in Cell Biology
  3. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition
    Federica Iannelli, Maria Serena Roca, Rita Lombardi, Chiara Ciardiello, Laura Grumetti, Simona De Rienzo, Tania Moccia, Carlo Vitagliano, Angela Sorice, Susan Costantini et al. · 2020 · Journal of Experimental & Clinical Cancer Research
  4. New Insights into YAP/TAZ-TEAD-Mediated Gene Regulation and Biological Processes in Cancer
    Yang Zhao, Marisela Sheldon, Yutong Sun, Li Ma · 2023 · Cancers
  5. Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma
    Yoshitaka Sekido · 2018 · Cancers
  6. Metformin suppresses proliferation and invasion of drug‐resistant breast cancer cells by activation of the Hippo pathway
    Jie Liu, Juan Li, He Chen, Ruiqi Wang, Pingping Li, Yi Miao, Peijun Liu · 2020 · Journal of Cellular and Molecular Medicine
  7. Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases
    Yue Yu, Xingli Su, Qiaohong Qin, Ying Hou, Xin Zhang, Hongmei Zhang, Min Jia, Yulong Chen · 2020 · Pharmacological Research
  8. Differential control of Yorkie activity by LKB1/AMPK and the Hippo/Warts cascade in the central nervous system
    Ieva Gailite, Birgit L. Aerne, Nicolas Tapon · 2015 · Proceedings of the National Academy of Sciences
  9. Role of Angiomotin‐like 2 mono‐ubiquitination on YAP inhibition
    Miju Kim, Minchul Kim, Seong‐Jun Park, Cheolju Lee, Dae‐Sik Lim · 2015 · EMBO Reports
  10. Regulation of TAZ in cancer
    Xin Zhou, Qun‐Ying Lei · 2016 · Protein & Cell
  11. Regulation of Tissue Growth by the Mammalian Hippo Signaling Pathway
    Kevin I. Watt, Kieran F. Harvey, Paul Gregorevic · 2017 · Frontiers in Physiology
  12. Metformin attenuates PD-L1 expression through activating Hippo signaling pathway in colorectal cancer cells.
    Junjie Zhang, Qiushi Zhang, Zi-Qian Li, Jiawang Zhou, Jun Du · 2019 · PubMed Central
  13. TAZ couples Hippo/Wnt signalling and insulin sensitivity through Irs1 expression
    Jun-Ha Hwang, A Rum Kim, Kyung Min Kim, Jung Il Park, Ho Taek Oh, Sung Ah Moon, Mi Ran Byun, Hana Jeong, Hyo Kyung Kim, Michael B. Yaffe et al. · 2019 · Nature Communications
  14. The hippo pathway: A master regulator of liver metabolism, regeneration, and disease
    Nguyen‐Lefebvre, Anh Thu, Selzner, Nazia, Wrana, Jeffrey L., Bhat, Mamatha · 2021 · The FASEB Journal
  15. Map4k4 Signaling Nodes in Metabolic and Cardiovascular Diseases
    Joseph V. Virbasius, Michael Czech · 2016 · Trends in Endocrinology and Metabolism
  16. Metformin: review of epidemiology and mechanisms of action in pancreatic cancer
    Guido Eibl, Enrique Rozengurt · 2021 · Cancer and Metastasis Reviews
  17. Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington’s Disease and Other Neurodegenerative Disorders
    Pasquale Sileo, C. Simonin, Patricia Melnyk, Marie‐Christine Chartier‐Harlin, Philippe Cotelle · 2022 · Cells
  18. Metformin mediates resensitivity to 5-fluorouracil in hepatocellular carcinoma via the suppression of YAP
    Yu Tian, Bo Tang, Chengye Wang, Deguang Sun, Rixin Zhang, Nan Luo, Han Zhao, Rui Liang, Zhenming Gao, Liming Wang · 2016 · Oncotarget
  19. Hippo‐Yap/Taz signaling: Complex network interactions and impact in epithelial cell behavior
    Benjamin J. van Soldt, Wellington Veras Cardoso · 2019 · Wiley Interdisciplinary Reviews Developmental Biology
  20. The Hippo signal transduction network for exercise physiologists
    Gabriel, Brendan M., Hamilton, D. Lee, Tremblay, Annie M., Wackerhage, Henning · 2016 · Journal of Applied Physiology
  21. Targeting Hippo signaling in cancer: novel perspectives and therapeutic potential
    Liemei Lv, Xiangxiang Zhou · 2023 · MedComm
  22. The endothelial E3 ligase HECW2 promotes endothelial cell junctions by increasing AMOTL1 protein stability via K63-linked ubiquitination
    Kyu-Sung Choi, Hyun-Jung Choi, Jin-Kyu Lee, Suhjean Im, Haiying Zhang, Yoonjeong Jeong, Jeong Ae Park, In‐Kyu Lee, Young‐Myeong Kim, Young‐Guen Kwon · 2016 · Cellular Signalling
  23. Targeting the Hippo signalling pathway for cancer treatment
    Keisuke Nakatani, Tomohiko Maehama, Miki Nishio, Hiroki Goto, Wakako Kato, Hirofumi Omori, Yosuke Miyachi, Hideru Togashi, Yohei Shimono, Akira Suzuki · 2016 · The Journal of Biochemistry
  24. Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow
    Dandan Liu, Hang Lv, Qi Liu, Yanli Sun, Shenglong Hou, Lu Zhang, Mengyue Yang, Baihe Han, Gang wang, Xuedong Wang et al. · 2019 · Journal of Translational Medicine
  25. Yap regulates skeletal muscle fatty acid oxidation and adiposity in metabolic disease
    K. Watt, D. Henstridge, M. Ziemann, C. Sim, M. Montgomery, D. Samocha-Bonet, B. Parker, G. Dodd, S. Bond, T. M. Salmi et al. · 2021 · Nature Communications
  26. AMPK at the interface of nutrient sensing, metabolic flux and energy homeostasis
    Tyler K.T. Smith, Logan K. Townsend, William J. Smiles, Jonathan S. Oakhill, Morgan D. Fullerton, Gregory R Steinberg · 2026 · Nature Metabolism
  27. The Hippo pathway: Organ size control and beyond
    Pengfei Guo, Sicheng Wan, Kun‐Liang Guan · 2024 · Pharmacological Reviews
  28. Repurposing of Drugs Targeting YAP-TEAD Functions
    Gian Marco Elisi, Matteo Santucci, Domenico D’Arca, Angela Lauriola, Gaetano Marverti, Lorena Losi, Laura Scalvini, María Laura Bolognesi, Marco Mor, Maria Paola Costi · 2018 · Cancers
  29. Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies
    Enrique Rozengurt, Guido Eibl · 2026 · Signal Transduction and Targeted Therapy
  30. Dapagliflozin delays renal fibrosis in diabetic kidney disease by inhibiting YAP/TAZ activation.
    Lan Feng, Yang Chen, Ningning Li, Xiao-Juan Yang, Lu Zhou, Hui-Rong Li, Ting-Ting Wang, Manjiang Xie, Hong-Bao Liu · 2023 · Life Science
  31. The regulatory networks of the Hippo signaling pathway in cancer development
    Maonan Wang, Manli Dai, Dan Wang, Wei Xiong, Zhaoyang Zeng, Can Jie Guo · 2021 · Journal of Cancer
  32. Metformin Syncs CeO2 to Recover Intra‐ and Extra‐Cellular ROS Homeostasis in Diabetic Wound Healing
    Mengyang Li, Yuhang Dong, Yage Shang, Jiaqi Liu, Yunchuan Wang, Dongliang Zhang, Lixia Zhang, Chao Han, Yue Zhang, Kuo Shen et al. · 2024 · Small
  33. Endothelial Cell Mechano-Metabolomic Coupling to Disease States in the Lung Microvasculature
    David Wu, Konstantin G. Birukov · 2019 · Frontiers in Bioengineering and Biotechnology
  34. Context-dependent transcriptional regulations of YAP/TAZ in stem cell and differentiation
    Juan Luo, Peng Li · 2022 · Stem Cell Research & Therapy
  35. The Hippo pathway, p53 and cholesterol
    Yael Aylon, Moshe Oren · 2016 · Cell Cycle
  36. The physiological role of Motin family and its dysregulation in tumorigenesis
    Tingting Huang, Yuhang Zhou, Jinglin Zhang, Alfred S.L. Cheng, Jun Qing Yu, Ka Fai To, Wei Kang · 2018 · Journal of Translational Medicine
  37. RETRACTED: The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC
    Dan Jin, Jiwei Guo, Deqiang Wang, Yan Wu, Xiaohong Wang, Yong Gao, Cuijie Shao, Xin Xu, Shuying Tan · 2018 · EBioMedicine · Retracted
  38. Stimulation of ovarian follicle growth after AMPK inhibition
    Xiaowei Lu, Song Guo, Yuan Cheng, Jae-hong Kim, Yi Feng, Yun Feng · 2017 · Reproduction
  39. Emerging role of Hippo signalling pathway in bladder cancer
    Jianling Xia, Ming Zeng, Hua Zhu, Xiangjian Chen, Zhiliang Weng, Shi Li · 2017 · Journal of Cellular and Molecular Medicine
  40. The mitochondrial deoxyguanosine kinase is required for cancer cell stemness in lung adenocarcinoma
    Shengchen Lin, Chongbiao Huang, Jianwei Sun, Oana Bollt, Xiuchao Wang, Eric Martine, Jiaxin Kang, Matthew D. Taylor, Bin Fang, Pankaj K. Singh et al. · 2019 · EMBO Molecular Medicine
  41. LATS kinase–mediated CTCF phosphorylation and selective loss of genomic binding
    Huacheng Luo, Qin Yu, Yang Liu, Ming Tang, Mingwei Liang, Dingpeng Zhang, Tsan Sam Xiao, Lizi Wu, Ming Tan, Yijun Ruan et al. · 2020 · Science Advances
  42. Human blood vessel organoids reveal a critical role for CTGF in maintaining microvascular integrity
    Sara G. Romeo, Ilaria Secco, Edoardo Schneider, Christina Maria Reumiller, Célio X.C. Santos, Anna Zoccarato, Vishal Musale, Aman Pooni, Xiaoke Yin, Konstantinos Theofilatos et al. · 2023 · Nature Communications
  43. Context-dependent transcriptional regulations of YAP/TAZ in cancer
    Yibo Guo, Juan Luo, Hailin Zou, Chenxin Liu, Liang Deng, Peng Li · 2021 · Cancer Letters
  44. Inhibition of YAP/TAZ Activity in Spinal Cord Suppresses Neuropathic Pain
    Ni Xu, Mingzheng Wu, Xueting Deng, Pingchuan Ma, Zehua Li, Lei Liang, Meng-Fan Xia, Dong Cui, Duan-duan He, Yuan Zong et al. · 2016 · Journal of Neuroscience
  45. Regulation of Hippo signaling pathway in cancer: A MicroRNA perspective
    Priyanka Samji, Manoj Kumar Rajendran, Vidya P. Warrier, Akshayaa Ganesh, Devarajan Karunagaran · 2020 · Cellular Signalling
  46. The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK/mTOR mediated glycolysis in colorectal cancer
    Gang Wang, Yang Yu, Yuzhu Wang, Peihao Yin, Ke Xu, Heng Zhang · 2020 · Artificial Cells Nanomedicine and Biotechnology
  47. The role of extracellular biophysical cues in modulating the Hippo-YAP pathway
    Jung‐Soon Mo · 2017 · BMB Reports
  48. Phase separation of YAP reorganizes genome topology for long-term, YAP target gene expression
    Danfeng Cai, Daniel Feliciano, Peng Dong, Eduardo Flores, Martin Gruebele, Natalie Porat‐Shliom, Shahar Sukenik, Zhe J. Liu, Jennifer Lippincott‐Schwartz · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  49. An Updated Understanding of the Role of YAP in Driving Oncogenic Responses
    Giampaolo Morciano, Bianca Vezzani, Sonia Missiroli, Caterina Boncompagni, Paolo Pinton, Carlotta Giorgi · 2021 · Cancers
  50. Prolonged Myocardial Regenerative Capacity in Neonatal Opossum
    Chihiro Nishiyama, Yuichi Saito, Akane Sakaguchi, Mari Kaneko, Hiroshi Kiyonari, Yuqing Xu, Yuichiro Arima, Hideki Uosaki, Wataru Kimura · 2022 · Circulation
  51. YAP ping about and not forgetting TAZ
    Bernard Andrew Callus, Megan Finch‐Edmondson, Sue Fletcher, Steve Donald Wilton · 2018 · FEBS Letters
  52. Sitagliptin affects gastric cancer cells proliferation by suppressing Melanoma‐associated antigen‐A3 expression through Yes‐associated protein inactivation
    Qi Wang, Lu Pan, Tao Wang, Qianqian Zheng, Yan Li, Sean Xiao Leng, Xin Meng, Biao Wang, Jisheng Xie, Haiyan Zhang · 2020 · Cancer Medicine
  53. Targeting AMP-activated protein kinase (AMPK) for treatment of autosomal dominant polycystic kidney disease
    Xuewen Song, Evangelia Evelyn Tsakiridis, Gregory R. Steinberg, York Pei · 2020 · Cellular Signalling
  54. Regulation of Hippo signaling by metabolic pathways in cancer
    Ukjin Lee, Eun-Young Cho, Eek‐hoon Jho · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  55. Endothelial H2S-AMPK dysfunction upregulates the angiocrine factor PAI-1 and contributes to lung fibrosis
    Xiangqi Chen, Han Wang, Chuan Fen Wu, Xiaoyan Li, Xiaojuan Huang, Yafeng Ren, Qiang Pu, Zhongwei Cao, Xiaoqiang Tang, Bi‐Sen Ding · 2024 · Redox Biology
  56. Development and Therapeutic Potential of NUAKs Inhibitors
    Muhammad Faisal, Jae Ho Kim, Kyung Ho Yoo, Eun Joo Roh, Soon Sun Hong, So Ha Lee · 2020 · Journal of Medicinal Chemistry
  57. Inhibitors Targeting YAP in Gastric Cancer: Current Status and Future Perspectives
    Jiaxin Yong, Yuan Li, Sihan Lin, Zhenning Wang, Yan Hua Xu · 2021 · Drug Design Development and Therapy
  58. Targeting AMPK Signaling in the Liver: Implications for Obesity and Type 2 Diabetes Mellitus
    Ying Liu, Doudou Wang, Lin Yang · 2022 · Current Drug Targets
  59. YAP Inhibition by Nuciferine via AMPK-Mediated Downregulation of HMGCR Sensitizes Pancreatic Cancer Cells to Gemcitabine
    Ling Zhou, Qiaoyun Wang, Han Zhang, Youjie Li, Shuyang Xie, Maolei Xu · 2019 · Biomolecules
  60. Catechol enhances chemo‑ and radio‑sensitivity by targeting AMPK/Hippo signaling in pancreatic cancer cells
    Jeong Moon, Meran Keshawa Ediriweera, Ji Ryu, Hee Jung Kim, Somi Kim Cho · 2021 · Oncology Reports
  61. YAP and TAZ Mediators at the Crossroad between Metabolic and Cellular Reprogramming
    Giorgia Di Benedetto, Silvia Parisi, Tommaso Russo, Fabiana Passaro · 2021 · Metabolites
  62. Yes-associated protein in the liver: Regulation of hepatic development, repair, cell fate determination and tumorigenesis
    Quy Pham Nguyen, Robert A. Anders, Gianfranco D. Alpini, Haibo Bai · 2015 · Digestive and Liver Disease
  63. LKB1 and YAP phosphorylation play important roles in Celastrol-induced β-catenin degradation in colorectal cancer
    Shuren Wang, Kai Ma, Cuiqi Zhou, Yu Wang, Guanghui Hu, Lechuang Chen, Zhuo Li, Chenfei Hu, Qing Xu, Hongxia Zhu et al. · 2019 · Therapeutic Advances in Medical Oncology
  64. Glucose promotes epithelial‐mesenchymal transitions in bladder cancer by regulating the functions of YAP1 and TAZ
    Shi Li, Hua Zhu, Hongde Chen, Jianling Xia, Fangyi Zhang, Ruoting Xu, Lin Qi · 2020 · Journal of Cellular and Molecular Medicine
  65. Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis
    Taha Azad, Reza Rezaei, Abera Surendran, Ragunath Singaravelu, Stephen Boulton, Jaahnavi Dave, John Cameron Bell, Carolina S. Ilkow · 2020 · Cancers
  66. Enhanced pentose phosphate pathway activity promotes pancreatic ductal adenocarcinoma progression via activating YAP/MMP1 axis under chronic acidosis
    Siyuan Chen, Bo Ning, Jin‐Wen Song, Zihan Yang, Li Zhou, Zhiji Chen, Lin‐Hong Mao, Hongtao Liu, Qingliang Wang, Song He et al. · 2022 · International Journal of Biological Sciences
  67. TNS1: Emerging Insights into Its Domain Function, Biological Roles, and Tumors
    Zhi-Hui Wang, Jing-Xue Ye, Fengrui Dong, Li Cao, Min Wang, Gui-Bo Sun · 2022 · Biology
  68. The Hippo pathway noncanonically drives autophagy and cell survival in response to energy stress
    Gayoung Seo, Clinton Yu, Han Han, Xing Li, Rebecca Elizabeth Kattan, Jeongmin An, Amrutha Kizhedathu, Bing Yang, Annabella Luo, Abigail L. Buckle et al. · 2023 · Molecular Cell
  69. Mst1/2 Kinases Modulate Glucose Uptake for Osteoblast Differentiation and Bone Formation
    Wenling Li, Yujie Deng, Bo Feng, Kinglun Kingston Mak · 2018 · Journal of Bone and Mineral Research
  70. The Snakeskin-Mesh Complex of Smooth Septate Junction Restricts Yorkie to Regulate Intestinal Homeostasis in Drosophila
    Hsi‐Ju Chen, Qi Li, Niraj K. Nirala, Yicktung Tony Ip · 2020 · Stem Cell Reports
  71. AMPK signaling inhibits the differentiation of myofibroblasts: impact on age-related tissue fibrosis and degeneration
    Antero Salminen · 2023 · Biogerontology
  72. Regulation of sensitivity of tumor cells to antitubulin drugs by Cdk1-TAZ signalling
    Yulei Zhao, Xiaolong Yang · 2015 · Oncotarget
  73. ΔNp63α in cancer: importance and therapeutic opportunities
    Matthew L. Fisher, Seamus Balinth, Alea A. Mills · 2022 · Trends in Cell Biology
  74. Targeting Hippo pathway: A novel strategy for Helicobacter pylori-induced gastric cancer treatment
    Yunyun Liu, Bingkai Zhang, Yimin Zhou, Yuanxin Xing, Yunshan Wang, Yanfei Jia, Duanrui Liu · 2023 · Biomedicine & Pharmacotherapy
  75. Hippo Signaling Pathway in Colorectal Cancer: Modulation by Various Signals and Therapeutic Potential
    Somayeh Mohammadpour, Amir Torshizi Esfahani, SeyedKasra Sarpash, Fatemeh Vakili, Nikta Zafarjafarzadeh, Amirhesam Mashaollahi, Ali Pardakhtchi, Ehsan Nazemalhosseini Mojarad · 2024 · Analytical Cellular Pathology
  76. Metabolic control of progenitor cell propagation during Drosophila tracheal remodeling
    Yue Li, Pengzhen Dong, Yang Yang, Tianyu Guo, Quanyi Zhao, Dan Miao, Huanle Li, Tianfeng Lu, Fanning Xia, Jialan Lyu et al. · 2022 · Nature Communications
  77. Profiles analysis reveals circular RNAs involving zebrafish physiological development
    Heng Liu, Yin Hu, Jing Yin, Xiangyun Yan, Wenjuan Chen, Cheng‐Yao Jiang, Xiaoshan Hu, Xing‐Yun Wang, Jingai Zhu, Zhangbin Yu et al. · 2019 · Journal of Cellular Physiology
  78. The cross-talk between the Hippo signaling pathway and autophagy:implications on physiology and cancer
    Fengyuan Tang, Gerhard Christofori · 2020 · Cell Cycle
  79. Central role of Yes-associated protein and WW-domain-containing transcriptional co-activator with PDZ-binding motif in pancreatic cancer development
    Enrique Rozengurt, Guido Eibl · 2019 · World Journal of Gastroenterology
  80. Reciprocal regulation of actin filaments and cellular metabolism
    Geyao Liu, Jiayi Li, Congying Wu · 2022 · European Journal of Cell Biology
  81. PARP-1 activation after oxidative insult promotes energy stress-dependent phosphorylation of YAP1 and reduces cell viability
    Sandra M. Martín‐Guerrero, Pedro Casado, Maruan Hijazi, Vinothini Rajeeve, Julio Plaza‐Díaz, Francisco Abadía‐Molina, Julio Navascués, Miguel Ángel Cuadros, Pedro R. Cutillas, David Martín‐Oliva · 2020 · Biochemical Journal
  82. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway
    Jinqiu Lu, Zonghao Hu, Yujie Deng, Qingzhe Wu, Ming Wu, Hai Xin Song · 2021 · Journal of Biological Chemistry
  83. AICAR Ameliorates Non-Alcoholic Fatty Liver Disease via Modulation of the HGF/NF-κB/SNARK Signaling Pathway and Restores Mitochondrial and Endoplasmic Reticular Impairments in High-Fat Diet-Fed Rats
    Doaa Hussein Zineldeen, Nahid Tahoon, Naglaa Sarhan · 2023 · International Journal of Molecular Sciences
  84. AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair
    Zhen Chen, Chao Wang, Antrix Jain, Mrinal Srivastava, Mengfan Tang, Huimin Zhang, Xu Feng, Litong Nie, Dan Su, Yun Xiong et al. · 2020 · Molecular & Cellular Proteomics
  85. Hippo signaling in regeneration and aging
    Dana Elster, Björn von Eyß · 2020 · Mechanisms of Ageing and Development
  86. Intraflagellar Transport Complex B Proteins Regulate the Hippo Effector Yap1 during Cardiogenesis
    Marina Peralta, Laia Ortiz López, Kateřina Jeřábková, Tommaso Lucchesi, Benjamin Vitre, Dong Han, Laurent Guillemot, Chaitanya Dingare, Izabela Sumara, Nadia Mercader et al. · 2020 · Cell Reports
  87. YAP1 activation and Hippo pathway signaling in the pathogenesis and treatment of intrahepatic cholangiocarcinoma
    Sungjin Ko, Minwook Kim, Laura Maria Molina, Alphonse Eugene Sirica, Satdarshan P. Monga · 2022 · Advances in cancer research
  88. Deregulation and Therapeutic Potential of the Hippo Pathway in Cancer
    Kimberly C. Lin, Hyun Woo Park, Kun‐Liang Guan · 2017 · Annual Review of Cancer Biology
  89. AMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis
    Mahbubul H. Shihan, Sachin Kr. Sharma, Carson Cable, Vijaya Prathigudupu, Alina J. Chen, Aras N. Mattis, Jennifer Y. Chen · 2024 · Scientific Reports
  90. RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer
    Evangelos Prokakis, Shaishavi Jansari, Angela Boshnakovska, Maria Wiese, Kathrin Kusch, Christof Maria Kramm, Christian Dullin, Peter Rehling, Markus Glatzel, Klaus Pantel et al. · 2023 · Cell Death and Disease
  91. Glucose activates the primordial follicle through the AMPK/mTOR signaling pathway
    Shengyu Xu, Xiaoling Wu, Yanpeng Dong, Mengmeng Xu, Zimei Li, Sirun Chen, Yong Zhuo, Yan Lin, Lianqiang Che, Zhengfeng Fang et al. · 2020 · Clinical and Translational Medicine
  92. The Emerging Link between the Hippo Pathway and Non-coding RNA
    Mayuko Shimoda, Toshiro Moroishi · 2019 · Biological and Pharmaceutical Bulletin
  93. YAP1 nuclear efflux and transcriptional reprograming follow membrane diminution upon VSV-G-induced cell fusion
    Daniel Feliciano, Carolyn M. Ott, Isabel Espinosa-Medina, Aubrey V. Weigel, Lorena Benedetti, Kristin M. Milano, Zhonghua Tang, Tzumin Lee, Harvey J. Kliman, Seth M. Guller et al. · 2021 · Nature Communications
  94. Hippo in Gastric Cancer: From Signalling to Therapy
    Lornella Seeneevassen, Pierre R. Dubus, Caroline Gronnier, Christine Varon · 2022 · Cancers
  95. Sestrin2 inhibits YAP activation and negatively regulates corneal epithelial cell proliferation
    Ji‐Su Lee, Hwan‐Woo Park, Kyong Jin Cho, Jungmook Lyu · 2020 · Experimental & Molecular Medicine
  96. Calpain-1 Up-Regulation Promotes Bleomycin-Induced Pulmonary Fibrosis by Activating Ferroptosis
    silin wei, Yu Liu, Chenyang Ran, Yunhan Li, Bailin Tang, Meili Lu, Hongxin Wang · 2024 · American Journal Of Pathology
  97. Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases
    Chao Yang, Limor Rubin, Xiyong Yu, Philip Lazarovici, Wenhua Zheng · 2024 · Medicinal Research Reviews
  98. The LKB1–TSSK1B axis controls YAP phosphorylation to regulate the Hippo–YAP pathway
    Cho-Long Kim, Su-Bin Lim, Sue-Hee Choi, Dong Hyun Kim, Ye Eun Sim, Eun-Hye Jo, Keeeun Kim, Keesook Lee, Hee-Sae Park, Su Bin Lim et al. · 2024 · Cell Death and Disease
  99. Angiomotin family proteins in the Hippo signaling pathway
    Yu Wang, Fa‐Xing Yu · 2024 · BioEssays
  100. Emerging roles for angiomotin in the nervous system
    Michael Wigerius, Dylan P. Quinn, James P. Fawcett · 2020 · Science Signaling